Dr. Diane Forbes Berthoud, Vice President and Chief Equity, Diversity, and Inclusion Officer at the University of Maryland, Baltimore, presented the third convening of Schools to discuss the State of Equity, Diversity, and inclusion at UMB. Dean Mark Gladwin of the School of Medicine gave a summary of the state of EDI at his school. In the fall of 2023, the University officially launched the university’s first ever Diversity Strategic Plan centered around the premise of REPS. Recruitment and Retention Experience Professional Development and Career Advancement Scholarship, Service, and Education To ensure greater accountability and strengthen the impact and sustainability of the Plan, each school will share a summary of the state of EDI in their area following the REPS structure and propose strategies for improvement.This event took place in person in the SMC Elm Ballrooms and virtually in this Zoom webinar.
More from Youtube
- 1:20HRT & Compounded Products: What Patients Should KnowNot all hormone replacement therapies are the same. Compounded products raise unique questions about safety and effectiveness.University of Maryland School of Medicine professor Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, explains the latest insights — helping patients and providers make informed choices.This research is supported by the U.S. Food and Drug Administration (FDA).#BreakthroughsCantWait #HormoneTherapy #FDAResearch #UMBresearch #WomensHealth
- 3:55CORE Values 2025
- 1:46Hormone Replacement Therapy: Risks, Benefits & Compounded ProductsWhat should patients and providers know about hormone replacement therapy (HRT)?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, professor of pharmaceutical sciences at the University of Maryland School of Pharmacy, explains the risks, benefits, and what to consider with compounded hormone products.This research is supported by the U.S. Food and Drug Administration (FDA).Learn more about how UMB researchers are advancing science: https://vist.ly/45nuc#HormoneReplacementTherapy #BreakthroughsCantWaitUMB #UMBresearch #FDAResearch
- 0:34FDA-Supported Menopause Research: Finding Safer Relief | Breakthroughs Can’t WaitMenopause symptoms like hot flashes and fatigue disrupt millions of women’s lives. University of Maryland, Baltimore researchers, supported by the U.S. Food and Drug Administration (FDA), are studying safer and more effective ways to manage symptoms—backed by science, not myths.Because breakthroughs can’t wait.#BreakthroughsCantWaitUMB #MenopauseResearch #WomensHealth #FDAResearch #FDAScience #HealthyAging
- 6:05What if Medicines Delivered Through the Skin Were More Precise?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, is working to ensure drug delivery through the skin is safe and effective, and just the right dose — especially for menopausal medicines.Although transdermal patches help patients maintain consistency with drug therapies, it is critical to ensure patients receive just the right dose often over long periods of time.Learn more at https://www.umaryland.edu/breakthroughs#FDA #BreakthroughsCantWaitUMB #Menopause #transdermalpatch
- 1:28How Global Health Research Protects America | Breakthroughs Can’t WaitCongress invests in global health research for one simple reason: diseases don’t stop at the ocean. By stopping outbreaks where they start, this UMB research protects Americans and strengthens global health security.Supported by the National Institutes of Health Fogarty International Center.#BreakthroughsCantWaitUMB #GlobalHealth #NIH #FogartyInternational #HealthSecurity #ResearchProtectsUs #Congress
